Learning Objectives

Upon completion of this course, the dental professional should be able to:

  • Discuss in general terms the approval process of new drugs and its limitations as they relate to ADRs.
  • Discuss “on-target,” “off-target,” and cytotoxic mechanisms of ADRs.
  • Develop a clinical frame of reference related to ADRs.
  • Discuss the spectrum of potential ADRs affecting the head and neck area and various organ systems associated with dental therapeutics and the top 200 drugs dispensed by U.S. community pharmacies.